These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38218213)

  • 1. Illuminating function of the understudied druggable kinome.
    Gomez SM; Axtman AD; Willson TM; Major MB; Townsend RR; Sorger PK; Johnson GL
    Drug Discov Today; 2024 Mar; 29(3):103881. PubMed ID: 38218213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dark Kinase Knowledgebase: an online compendium of knowledge and experimental results of understudied kinases.
    Berginski ME; Moret N; Liu C; Goldfarb D; Sorger PK; Gomez SM
    Nucleic Acids Res; 2021 Jan; 49(D1):D529-D535. PubMed ID: 33079988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Illuminating the dark kinome: utilizing multiplex peptide activity arrays to functionally annotate understudied kinases.
    Hamoud AR; Alganem K; Hanna S; Morran M; Henkel N; Imami AS; Ryan W; Sahay S; Pulvender P; Kunch A; Arvay TO; Meller J; Shukla R; O'Donovan SM; McCullumsmith R
    Cell Commun Signal; 2024 Oct; 22(1):501. PubMed ID: 39415254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KinOrtho: a method for mapping human kinase orthologs across the tree of life and illuminating understudied kinases.
    Huang LC; Taujale R; Gravel N; Venkat A; Yeung W; Byrne DP; Eyers PA; Kannan N
    BMC Bioinformatics; 2021 Sep; 22(1):446. PubMed ID: 34537014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KSFinder-a knowledge graph model for link prediction of novel phosphorylated substrates of kinases.
    Anandakrishnan M; Ross KE; Chen C; Shanker V; Cowart J; Wu CH
    PeerJ; 2023; 11():e16164. PubMed ID: 37818330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing the role of the dark kinome in neurodegenerative disease - A mini review.
    Axtman AD
    Biochim Biophys Acta Gen Subj; 2021 Dec; 1865(12):130014. PubMed ID: 34547390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale proteomics analysis of the human kinome.
    Oppermann FS; Gnad F; Olsen JV; Hornberger R; Greff Z; Kéri G; Mann M; Daub H
    Mol Cell Proteomics; 2009 Jul; 8(7):1751-64. PubMed ID: 19369195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical Kinase Index: A Method to Prioritize Understudied Kinases as Drug Targets for the Treatment of Cancer.
    Essegian D; Khurana R; Stathias V; Schürer SC
    Cell Rep Med; 2020 Oct; 1(7):100128. PubMed ID: 33205077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitor.
    Tamir TY; Drewry DH; Wells C; Major MB; Axtman AD
    Sci Rep; 2020 Sep; 10(1):15826. PubMed ID: 32985588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting protein and pathway associations for understudied dark kinases using pattern-constrained knowledge graph embedding.
    Salcedo MV; Gravel N; Keshavarzi A; Huang LC; Kochut KJ; Kannan N
    PeerJ; 2023; 11():e15815. PubMed ID: 37868056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence and utility of intrinsically disordered regions in kinases.
    Kathiriya JJ; Pathak RR; Clayman E; Xue B; Uversky VN; Davé V
    Mol Biosyst; 2014 Nov; 10(11):2876-88. PubMed ID: 25099472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A targeted quantitative proteomics strategy for global kinome profiling of cancer cells and tissues.
    Xiao Y; Guo L; Wang Y
    Mol Cell Proteomics; 2014 Apr; 13(4):1065-75. PubMed ID: 24520089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How many kinases are druggable? A review of our current understanding.
    Anderson B; Rosston P; Ong HW; Hossain MA; Davis-Gilbert ZW; Drewry DH
    Biochem J; 2023 Aug; 480(16):1331-1363. PubMed ID: 37642371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemogenomic Analysis of the Druggable Kinome and Its Application to Repositioning and Lead Identification Studies.
    Ravikumar B; Timonen S; Alam Z; Parri E; Wennerberg K; Aittokallio T
    Cell Chem Biol; 2019 Nov; 26(11):1608-1622.e6. PubMed ID: 31521622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical Probes for Understudied Kinases: Challenges and Opportunities.
    Serafim RAM; Elkins JM; Zuercher WJ; Laufer SA; Gehringer M
    J Med Chem; 2022 Jan; 65(2):1132-1170. PubMed ID: 34477374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug target ontology to classify and integrate drug discovery data.
    Lin Y; Mehta S; Küçük-McGinty H; Turner JP; Vidovic D; Forlin M; Koleti A; Nguyen DT; Jensen LJ; Guha R; Mathias SL; Ursu O; Stathias V; Duan J; Nabizadeh N; Chung C; Mader C; Visser U; Yang JJ; Bologa CG; Oprea TI; Schürer SC
    J Biomed Semantics; 2017 Nov; 8(1):50. PubMed ID: 29122012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The generality of kinase-catalyzed biotinylation.
    Senevirathne C; Embogama DM; Anthony TA; Fouda AE; Pflum MK
    Bioorg Med Chem; 2016 Jan; 24(1):12-9. PubMed ID: 26672511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Illuminating the understudied GPCR-ome.
    Majumdar S; Chiu YT; Pickett JE; Roth BL
    Drug Discov Today; 2024 Mar; 29(3):103848. PubMed ID: 38052317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KinomeRun: An interactive utility for kinome target screening and interaction fingerprint analysis towards holistic visualization on kinome tree.
    Ansar S; Vetrivel U
    Chem Biol Drug Des; 2020 Oct; 96(4):1162-1175. PubMed ID: 32418310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Darkness of the Human Kinome from a Medicinal Chemistry Perspective.
    Voßen S; Xerxa E; Bajorath J
    J Med Chem; 2024 Oct; 67(19):17919-17928. PubMed ID: 39320975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.